p27: A potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior
- 1 October 2001
- journal article
- Published by Elsevier in Human Pathology
- Vol. 32 (10) , 1094-1101
- https://doi.org/10.1053/hupa.2001.28234
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human CancersThe American Journal of Pathology, 1999
- The Prognostic Significance of Altered Cyclin-Dependent Kinase Inhibitors in Human CancerAnnual Review of Medicine, 1999
- Role of the cyclin-dependent kinase inhibitors in the development of cancerBlood, 1995
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Principles of CDK regulationNature, 1995
- p53-Independent Expression of p21 Cip1 in Muscle and Other Terminally Differentiating CellsScience, 1995
- Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product.The EMBO Journal, 1995
- pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrestNature, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- Immunodetection of Proliferating Cell Nuclear Antigen Assesses the Growth Fraction and Predicts Malignancy in Endocrine Tumors of the PancreasThe American Journal of Surgical Pathology, 1992